Insider Trading Alert - FRME, ICCC And REIS Traded By Insiders

Yesterday, Sept. 3, 2015, 102 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $57.69 to $16,858,584.42.

Highlighted Stocks Traded by Insiders:

First Merchants (FRME) - FREE Research Report

Sherman Patrick A, who is Director at First Merchants, bought 19 shares at $25.81 on Sept. 3, 2015. Following this transaction, the Director owned 29,137 shares meaning that the stake was boosted by 0.07% with the 19-share transaction.

Lehman Gary, who is Director at First Merchants, bought 65 shares at $25.81 on Sept. 3, 2015. Following this transaction, the Director owned 24,486 shares meaning that the stake was boosted by 0.26% with the 65-share transaction.

The shares most recently traded at $25.91, up $0.10, or 0.39% since the insider transaction. Historical insider transactions for First Merchants go as follows:

  • 4-Week # shares bought: 100
  • 4-Week # shares sold: 1,600
  • 12-Week # shares bought: 330
  • 12-Week # shares sold: 1,600
  • 24-Week # shares bought: 684
  • 24-Week # shares sold: 1,600

The average volume for First Merchants has been 156,600 shares per day over the past 30 days. First Merchants has a market cap of $986.4 million and is part of the financial sector and banking industry. Shares are up 14.64% year-to-date as of the close of trading on Thursday.

First Merchants Corporation operates as the financial holding company for First Merchants Bank, National Association that provides community banking services. The stock currently has a dividend yield of 1.69%. The company has a P/E ratio of 14.8. Currently, there is 1 analyst who rates First Merchants a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FRME - FREE

TheStreet Quant Ratings rates First Merchants as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, compelling growth in net income and expanding profit margins. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full First Merchants Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

ImmuCell (ICCC) - FREE Research Report

Rothschild Jonathan E, who is Director at ImmuCell, bought 3,000 shares at $6.63 on Sept. 3, 2015. Following this transaction, the Director owned 524,636 shares meaning that the stake was boosted by 0.58% with the 3,000-share transaction.

Tomsche David Scott, who is Director at ImmuCell, bought 1,000 shares at $6.73 on Sept. 3, 2015. Following this transaction, the Director owned 59,168 shares meaning that the stake was boosted by 1.72% with the 1,000-share transaction.

The shares most recently traded at $7.03, up $0.30, or 4.27% since the insider transaction. Historical insider transactions for ImmuCell go as follows:

  • 4-Week # shares bought: 7,600
  • 12-Week # shares bought: 7,600
  • 24-Week # shares bought: 7,600

The average volume for ImmuCell has been 18,700 shares per day over the past 30 days. ImmuCell has a market cap of $20.8 million and is part of the health care sector and drugs industry. Shares are up 44.65% year-to-date as of the close of trading on Thursday.

ImmuCell Corporation develops, acquires, manufactures, and sells products that enhance animal health and productivity in the dairy and beef industries in the United States and internationally. The company has a P/E ratio of 30.9.

Exclusive Offer: Get the latest Stock Analysis on ICCC - FREE

TheStreet Quant Ratings rates ImmuCell as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, reasonable valuation levels and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full ImmuCell Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Reis (REIS) - FREE Research Report

Sander William, who is COO of Reis Services, LLC at Reis, sold 1,000 shares at $24.29 on Sept. 3, 2015. Following this transaction, the COO of Reis Services, LLC owned 119,354 shares meaning that the stake was reduced by 0.83% with the 1,000-share transaction.

The shares most recently traded at $25.04, up $0.75, or 3% since the insider transaction. Historical insider transactions for Reis go as follows:

  • 4-Week # shares sold: 1,000
  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 83,826

The average volume for Reis has been 31,600 shares per day over the past 30 days. Reis has a market cap of $279.4 million and is part of the services sector and diversified services industry. Shares are down 5.81% year-to-date as of the close of trading on Thursday.

Reis, Inc., through its subsidiary, Reis Services, provides commercial real estate market information and analytical tools to real estate professionals in the United States. The stock currently has a dividend yield of 2.25%. The company has a P/E ratio of 42.9. Currently, there are 2 analysts who rate Reis a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on REIS - FREE

TheStreet Quant Ratings rates Reis as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins and good cash flow from operations. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Reis Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Elon Musk 'Should Be Quiet,' as 'Funding Secured' Still a Legal Concern

Elon Musk 'Should Be Quiet,' as 'Funding Secured' Still a Legal Concern

Dow Posts Solid Gains as Turkey Crisis Stabilizes; Home Depot Wavers

Dow Posts Solid Gains as Turkey Crisis Stabilizes; Home Depot Wavers

Jim Cramer on Tapestry: Accessories Are the Hottest Area of Retail

Jim Cramer on Tapestry: Accessories Are the Hottest Area of Retail

Jim Cramer on Tuesday's Market Gains: Let's Not Get Carried Away

Jim Cramer on Tuesday's Market Gains: Let's Not Get Carried Away

Jim Cramer on Home Depot, Tapestry, Nordstrom and Square

Jim Cramer on Home Depot, Tapestry, Nordstrom and Square